Healthcare
Infection results in 30 seconds, with over 60,000 validation tests
Product Overview
At NanoAi Health's core lies a highly sensitive sensor in its handheld breathalyzer, a marvel of nanotechnology. This handheld breathalyzer's sensor can detect trace amounts of specific chemicals in a breath sample, potentially indicating exposure to SARS-CoV-2, the virus behind COVID-19, and even variant strains. This translates to a fast, non-invasive screening method ideal for high-traffic areas like cruise ships, schools, concert venues, and sporting events. The benefits extend far beyond simple screening. The NanoAi Breath Analyzer can pinpoint the most contagious stage of an individual's infection. Aggregated data paints a picture of emerging viral hotspots within businesses and public spaces. Armed with this real-time information, health officials can take targeted action to control outbreaks. This empowers them to create safer environments for everyone, fostering a sense of security in populated settings. But the power of NanoAi doesn't stop there. Test results are securely transmitted to the NanoAi Technologies Secure Cloud. Here, a suite of analytical tools goes into action. Using artificial intelligence (AI), the software meticulously reviews each patient's data, pinpointing specific concentrations of the virus in different regions. This not only provides individual patient insights, but also allows researchers to track the spread and prevalence of the virus in real-time.